Ratanapornsompong Wattanachai, Pacharatakul Suthep, Sangkum Premsant, Leenanupan Chareon, Kongcharoensombat Wisoot
Division of Urology, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Division of Urology, Department of Surgery, Police Hospital, Bangkok, Thailand.
Asian J Urol. 2021 Jul;8(3):260-268. doi: 10.1016/j.ajur.2020.11.002. Epub 2020 Nov 7.
To prove the effectiveness of puboprostatic ligament-preserving robotic-assisted laparoscopic radical (RARP) on enhancing early continence.
Ninety-two patients with localized adenocarcinoma of the prostate scheduled for RARP from April 2018 to January 2019 were prospectively single-blinded and randomized into two groups, standard RARP (Group A) and puboprostatic ligament-sparing RARP (Group B). The outcomes were continent status at Foley catheter removal and 3 months after surgery using the score from the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF), pad usage, pathological margin status, blood loss, operative time, and complications.
Ninety-six patients were randomized (46 patients in each group), with a mean±SD age of 67.30±6.07 years. There were no differences in baseline characteristics. At 3 months after surgery, ICIQ-UI SF score (mean±SD) in Group A was significantly higher than Group B (8.74±4.28 6.93±3.96, =0.038) but no difference at Foley catheter removal. Group A also had a significant higher score for interference with daily life (median [interquartile range, IQR]: 4 [1, 5] 2 [0, 4]; =0.041) and higher pad use (median [IQR]: 2 [0, 3] 1 [1, 2]; =0.041) at 3 months. One case in Group A had complete or severe incontinence (>5 pads/day) at 3 months. Groups A and B did not exhibit significant difference in margin status (=0.828). There were no differences in operative time, blood loss, drain output or complications.
Use of puboprostatic ligament-sparing RARP could be a method to accelerate early continence without affecting the final oncological outcome.
证明保留耻骨前列腺韧带的机器人辅助腹腔镜根治术(RARP)在促进早期控尿方面的有效性。
2018年4月至2019年1月计划行RARP的92例局限性前列腺腺癌患者进行前瞻性单盲随机分组,分为标准RARP组(A组)和保留耻骨前列腺韧带的RARP组(B组)。观察指标包括拔除 Foley 导尿管时及术后3个月的控尿状态,采用国际尿失禁咨询委员会尿失禁简表(ICIQ-UI SF)评分、尿垫使用情况、病理切缘状态、失血量、手术时间及并发症。
96例患者被随机分组(每组46例),平均年龄(均值±标准差)为67.30±6.07岁。基线特征无差异。术后3个月,A组的ICIQ-UI SF评分(均值±标准差)显著高于B组(8.74±4.28对6.93±3.96,P = 0.038),但拔除Foley导尿管时无差异。A组在术后3个月时对日常生活的干扰评分也显著更高(中位数[四分位间距,IQR]:4[1,5]对2[0,4];P = 0.041),尿垫使用量也更多(中位数[IQR]:2[0,3]对1[1,2];P = 0.041)。A组有1例患者在术后3个月出现完全或严重尿失禁(>5片尿垫/天)。A组和B组在切缘状态方面无显著差异(P = 0.828)。手术时间、失血量、引流量或并发症方面无差异。
采用保留耻骨前列腺韧带的RARP可能是一种加速早期控尿且不影响最终肿瘤学结局的方法。